Oracle Stock Price Prediction: Will ORCL Hit $300 in 2026?
Any honest Oracle stock price prediction has to start with the tension at the center of the stock: Oracle is winning enormous AI cloud contracts, and it is spending almost as fast as it is booking them. After the company reported fiscal Q4 2026 results on June 10, ORCL slid from roughly $201 to around $192 even as revenue and backlog hit records. That gap — record bookings, falling stock — is the whole story.

So here is the direct answer. Wall Street's 12-month view is bullish, with an average target in the mid-$250s and the most aggressive analysts now at $300. Hitting that level is plausible but not automatic: it depends on Oracle converting a historic backlog into delivered, profitable cloud revenue without its ballooning capital spending swallowing the upside. Below is why the number could work, and where it could break.
Why this matters now: Oracle has repositioned itself from a legacy database vendor into one of the few credible "AI infrastructure landlords." That re-rating is most of the move in the stock over the past two years. The Q4 print is the first real test of whether the backlog is revenue or just a promise.
The quick answer: where ORCL stands now
As of June 10, 2026, ORCL traded around $192, off an intraday high near $212 and down from about $201 the prior session. The pullback came despite a record quarter — a classic "sell the news" reaction complicated by Oracle's plan to raise fresh capital. The consensus analyst rating remains Buy across roughly 35 covering analysts.
| Metric | Value (as of June 10, 2026) |
|---|---|
| Share price | ~$192 |
| Consensus rating | Buy (~35 analysts) |
| Avg 12-month target | ~$255 |
| High-end target | $300 |
| Low-end algo forecast | ~$180s |
| FY2027 revenue guide | $90B |
| FY2027 non-GAAP EPS guide | $8.05 (+18%) |
What just happened: Q4 FY2026 in numbers
The quarter was genuinely strong on the top line. The market's hesitation was about cost, not demand.
| Q4 FY2026 metric | Result | Change (YoY) |
|---|---|---|
| Total revenue | $19.2B | +21% |
| Total cloud revenue | $9.9B | +47% |
| Cloud infrastructure (OCI) | $5.8B | +93% |
| Cloud applications | $4.1B | +10% |
| EPS (GAAP) | $1.45 | +21% |
| EPS (non-GAAP) | $2.11 | +24% |
| Remaining Performance Obligations (RPO) | $638B | +$85B in the quarter |
| Capital expenditures | $55.7B (FY) | +162% |
The headline is the $638 billion RPO backlog, up from $553 billion, driven by large-scale AI contracts. But read the footnote: Oracle disclosed that about $75 billion of the increase was tied to deals where customers prepaid for GPUs or supplied the hardware themselves. That inflates the backlog optically and tells you these are capital-heavy, lower-margin arrangements, not classic high-margin software.
To fund the buildout, Oracle said it plans to raise about $40 billion in FY2027 through debt and equity, including a roughly $20 billion share sale. New shares dilute existing holders, and that is a large part of why the stock fell on otherwise record numbers.
Oracle stock price prediction: analyst targets and scenarios
Analyst models and algorithmic forecasts tell different stories, and the better reading is to weight them differently. Sell-side targets are anchored to earnings and guidance; multi-year algorithmic forecasts are trend extrapolations and deserve far more skepticism.
| Scenario | 12-month view | Rough price zone | What has to be true |
|---|---|---|---|
| Bull | Backlog converts fast, OCI margins hold | $290–$300+ | AI revenue lands on schedule, dilution is absorbed |
| Base | Steady cloud growth, heavy spend | $250–$270 | FY27 guidance ($90B rev) is met, margins stable |
| Bear | Capex outruns revenue, margin squeeze | $150–$185 | Delivery slips or financing costs bite |
Recent target revisions cluster bullish: Bank of America moved to $240, Oppenheimer to $275, and TD Cowen to $300, all maintaining Buy/Outperform. Longer-horizon third-party forecasts for 2027–2030 scatter widely — from the low $180s to $600-plus — which mostly tells you that multi-year point forecasts on a stock this capital-intensive are guesses dressed as precision. Treat any single 2030 number as a storyline, not a price.
The bull case — and the bill that comes with it
The bull case is simple and real: Oracle has become a preferred home for AI training and inference workloads, OCI is compounding near triple digits, and a $638 billion backlog gives multi-year revenue visibility most software firms can only envy. If even a clean majority of that converts at decent margins, $300 is reachable and FY2027's $90 billion revenue target looks conservative.
The more important point bulls gloss over is the bill. Capex up 162% to $55.7 billion, plus $40 billion of new financing, means Oracle is borrowing and issuing stock to build data centers for revenue it has not yet delivered. That is a leveraged bet on execution. It can work spectacularly — or it can compress free cash flow and the multiple at the same time if delivery slips.
The bear case most forecasts underweight
Three risks rarely make it into the cheerful year-by-year tables:
- Margin mix. GPU-prepaid and customer-supplied-hardware deals are not 80%-margin software. A backlog that swells on low-margin infrastructure is worth less per dollar than the headline implies.
- Dilution and debt. A ~$20 billion share sale and heavy borrowing arrive while interest costs are non-trivial. Every new share is a claim on the same earnings.
- Customer concentration and timing. A handful of very large AI customers drive the backlog. Delays, renegotiations, or a single pullback would hit both revenue and sentiment hard.
What experienced traders actually watch
Seasoned operators don't trade the press release; they trade the follow-through. Around an ORCL print, the traps are familiar: chasing the post-earnings spike before the dilution math sinks in, and treating RPO as if it were cash in the bank. The cleaner tells in coming quarters are OCI revenue actually delivered (not just booked), the gross-margin trend as hardware-heavy deals ramp, and free cash flow against that $55.7 billion capex line. If you also trade digital assets, you can watch how AI-infrastructure sentiment moves across both equities and crypto on a single markets dashboard, since the same AI narrative drives risk appetite in both.
Market view: The most useful framing is that ORCL is no longer priced as a software stock — it is priced as an AI-infrastructure buildout. That means the stock will likely trade on delivery and cash flow, not bookings. The $300 target is achievable, but the path runs through execution, not enthusiasm.
FAQ
1. What is the Oracle stock price prediction for 2026? Analyst 12-month targets center in the mid-$250s, with a bullish high near $300 and a more cautious low in the $150s–$180s. The range is wide because it hinges on how quickly Oracle's AI cloud backlog converts to delivered, profitable revenue against very heavy capital spending.
2. Why did ORCL stock fall after record Q4 FY2026 earnings? Revenue, cloud growth, and the $638B backlog all hit records, but Oracle also announced plans to raise about $40B (including a ~$20B share sale) and reported capex up 162%. Dilution and spending concerns outweighed the strong top line, pushing shares from about $201 to near $192.
3. Can Oracle stock reach $300? Yes, it's within the most bullish analyst targets. It would require Oracle to convert its AI backlog on schedule and at healthy margins while absorbing new share issuance. It is a realistic bull case, not a base case.
4. What is Oracle's RPO backlog and why does it matter? Remaining Performance Obligations are contracted revenue not yet recognized. Oracle's RPO jumped to $638B, signaling multi-year demand. The caveat: roughly $75B of the recent increase came from GPU-prepaid or customer-supplied-hardware deals, which are lower-margin than traditional software.
5. Is Oracle stock a buy right now? The consensus rating is Buy, but "consensus" is not a guarantee. The decision depends on your view of execution risk, tolerance for capex-driven volatility, and time horizon. This article is information, not investment advice — do your own research.
Risk Warning
Equities such as Oracle (ORCL) and crypto assets are volatile and can result in partial or total loss of capital. This article is for information only and is not investment advice, a recommendation, or a price guarantee. Oracle's outlook carries specific risks: heavy capital expenditure, new debt and equity issuance (dilution), customer concentration in large AI contracts, margin pressure from hardware-heavy deals, and broad macro or interest-rate shifts. Forecasts and analyst targets are estimates that frequently prove wrong. If you trade with leverage — in equities, futures, or crypto — losses can exceed your initial margin. Never invest more than you can afford to lose, size positions deliberately, and consider a licensed financial professional before acting.
You may also like

If You Can’t Buy TSLA Stocks, What Are the Trading Alternatives?
If you want exposure to TSLA but can’t open a U.S. brokerage account, this guide explains practical routes…

If You Can’t Buy CRDO Stocks, What Are the Trading Alternatives?
If you’re trying to access CRDO (Credo Technology Group) but can’t open a US brokerage account, this guide…

Where to Buy QQQ Stocks If You Don’t Have Brokerage Access
If you want exposure to QQQ but don’t have a US brokerage account, you have several paths. This…

If You Can’t Buy CRCL Stocks, What Are the Trading Alternatives?
CRCL tracks Circle Internet Group, a key stablecoin and payments player tied to USDC. If you can’t open…

Where to Buy SPY Stocks If You Don’t Have Brokerage Access
If you can’t open a US brokerage account but still want exposure to SPY, there are workable routes.…

If You Can’t Buy NBIS Stocks, What Are the Trading Alternatives?
NBIS has been volatile and news-heavy in 2026, but many readers face hurdles opening US brokerage accounts. This…

World Cup 2026 Schedule: Key Matches Fans Are Watching
The World Cup Schedule for 2026 is packed with high-attention group-stage fixtures that bring Lionel Messi, Cristiano Ronaldo,…

Where and How to Buy DKNG Stocks and What If You Can’t Access Them
DKNG (DraftKings Inc.) attracts both stock investors and crypto-native traders seeking exposure to US equities. This guide explains…

Where to Buy ASML Stocks If You Don’t Have Brokerage Access
If you want exposure to ASML’s price but can’t open a US brokerage account, you still have options.…

Will Messi Play in World Cup 2026? What Fans Are Watching
Lionel Messi’s status for FIFA World Cup 2026 sits at the center of global conversation. This article explains…

Spain Lamine Yamal: What Fans Are Watching in 2026
Lamine Yamal has become a central talking point for Spain football heading into FIFA World Cup 2026. This…

What Is USDC? A Beginner’s Guide to the USD Coin Stablecoin in 2026
USDC is a dollar-pegged stablecoin issued by Circle that aims to hold a steady $1 price, making it…

USDC vs USDT: What’s the Difference and Which Stablecoin Is Better?
This guide compares USDC and USDT in plain terms: what backs them, how redemptions work, where liquidity is…

How to Buy USDC: A Step-by-Step Guide for Beginners in 2026
This guide explains what USDC is, how to buy USDC with a card, bank transfer, P2P, or a…

What Is Solscan? A Beginner’s Guide to the Solana Blockchain Explorer
Solscan is a blockchain explorer for Solana that lets you search wallet addresses, track transactions, analyze tokens, view…

Solscan vs Solana Explorer: Which Tool Is Better for Crypto Traders?
Solana traders often bounce between solscan and the official Solana Explorer when they need fast answers: what just…

What Is Arkham (ARKM)? Everything You Need to Know in 2026
Arkham (ARKM) is a crypto-intelligence project built to map blockchain addresses to real-world entities and make on-chain activity…

Is ARKM a Good Investment? What Crypto Investors Should Know
ARKM is the native token of Arkham Intelligence, a crypto analytics platform and bounty marketplace that pays users…
If You Can’t Buy TSLA Stocks, What Are the Trading Alternatives?
If you want exposure to TSLA but can’t open a U.S. brokerage account, this guide explains practical routes…
If You Can’t Buy CRDO Stocks, What Are the Trading Alternatives?
If you’re trying to access CRDO (Credo Technology Group) but can’t open a US brokerage account, this guide…
Where to Buy QQQ Stocks If You Don’t Have Brokerage Access
If you want exposure to QQQ but don’t have a US brokerage account, you have several paths. This…
If You Can’t Buy CRCL Stocks, What Are the Trading Alternatives?
CRCL tracks Circle Internet Group, a key stablecoin and payments player tied to USDC. If you can’t open…
Where to Buy SPY Stocks If You Don’t Have Brokerage Access
If you can’t open a US brokerage account but still want exposure to SPY, there are workable routes.…
If You Can’t Buy NBIS Stocks, What Are the Trading Alternatives?
NBIS has been volatile and news-heavy in 2026, but many readers face hurdles opening US brokerage accounts. This…




